Fisetine voor een lang leven: Een gids over dit senolytische flavonoïde

The research-backed senolytic protocol uses 20 mg/kg body weight per day for 2 consecutive days, then 4–12 weeks off. For a 70 kg (154 lb) person, that's approximately 1,400 mg per day during the 2-day treatment window. For general antioxidant support (not senolytic), 100–500 mg daily is commonly used. Always start with a lower dose to assess tolerance before progressing to full clinical trial dosing.

In some studies, fisetin appears more potent than quercetin alone as a senolytic. However, quercetin is better studied as part of the dasatinib+quercetin (D+Q) combination, which may be more potent than fisetin overall. Fisetin's main advantage is accessibility—it's effective as a single agent and available over the counter, while D+Q requires a prescription for dasatinib. Many longevity researchers suggest combining fisetin and quercetin for multi-pathway coverage.

No. Strawberries are the richest food source at approximately 160 micrograms per gram, but reaching the senolytic dose of 1,400 mg would require eating roughly 19 pounds of strawberries in a single day—physically impossible and nutritionally inadvisable. Dietary strawberry intake provides antioxidant and anti-inflammatory benefits but not senolytic effects. Supplementation is necessary for therapeutic fisetin doses.

For senolytic purposes, the protocol is intermittent—not daily. Take high-dose fisetin (20 mg/kg) for 2 consecutive days, then stop for 4–12 weeks before repeating. Most self-experimenters cycle quarterly. For general health benefits at lower doses (100–500 mg), daily use is an option, though this likely won't achieve senolytic effects. The pulsed approach mimics clinical trial protocols.

Short-term fisetin use appears safe based on clinical trial data, with mild GI discomfort as the most common side effect. No serious adverse events have been reported in published studies. However, long-term safety data in humans is limited. People on blood thinners should use caution due to potential anticoagulant effects. Pregnant and breastfeeding women should avoid fisetin. Always consult a healthcare provider before starting supplementation.

Liposomal fisetin offers the best bioavailability, potentially improving absorption 10–25 fold compared to standard powder. Formulations using Novusetin branded extract (95%+ purity) provide research-grade quality. Bio-Fisetin with galactomannan fiber matrix is another enhanced-absorption option. At minimum, take any fisetin supplement with a fatty meal to improve absorption, as fisetin is lipophilic (fat-soluble).

In aged mice, fisetin extended both median and maximum lifespan in the landmark 2018 Yousefzadeh study. However, lifespan extension has not been proven in humans. Multiple clinical trials are currently testing fisetin for frailty, osteoarthritis, cognitive decline, and vascular aging, but results for longevity-specific endpoints will take years to accumulate. Fisetin is a promising but unproven longevity intervention for humans.

The best candidates are adults over 60 with age-related conditions (osteoarthritis, metabolic syndrome, chronic inflammation) who have already optimized lifestyle foundations (exercise, diet, sleep). People comfortable with experimental interventions and interested in cutting-edge longevity science may also benefit. Young, healthy individuals in their 20s–40s, pregnant women, and people on blood thinners should generally avoid fisetin supplementation.

Yes, combining fisetin and quercetin is a strategy some longevity researchers suggest for multi-pathway senolytic coverage. The two flavonoids target overlapping but not identical anti-apoptotic pathways in senescent cells. Some supplements now combine both in a single product. If stacking them, use the same intermittent pulsed protocol rather than daily dosing for senolytic purposes.

Don't expect immediate noticeable effects. Senolytic benefits accumulate gradually—reduced inflammatory markers may appear within weeks to months, improved physical function over months, and potential disease prevention benefits over years. Most people won't "feel" dramatically different after a single fisetin cycle. Track biomarkers if possible, and evaluate subjectively over 6–12 months of regular quarterly cycles.

The most commonly reported side effects of high-dose fisetin (20 mg/kg for 2 days) are mild gastrointestinal symptoms: nausea, stomach discomfort, and diarrhea. Some people report headache or a mild stimulant-like effect. These typically resolve within 24–48 hours after completing the dosing cycle. No serious adverse events have been reported in clinical trials at this dose and duration.

No. Fisetin is classified as a dietary supplement, not an FDA-approved drug. It is not approved for anti-aging, senolytic, or any therapeutic indication. While it's legally available for purchase as a supplement, this means it hasn't undergone the rigorous approval process required for pharmaceutical drugs. Quality and purity can vary between brands—choose third-party tested products from reputable manufacturers.